What is the management plan for a new Mobitz (second-degree atrioventricular block) II block?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of New Mobitz II Atrioventricular Block

Permanent pacemaker implantation is recommended for all patients with newly diagnosed Mobitz type II second-degree atrioventricular block, regardless of symptoms, due to high risk of progression to complete heart block and sudden death. 1

Initial Assessment and Stabilization

  • Hemodynamic stability assessment:

    • If unstable with symptomatic bradycardia: Administer atropine 0.5 mg IV (may repeat to maximum 3.0 mg) 1
    • Note: Atropine may be ineffective in Mobitz II block as the block is typically below the AV node 1
    • Consider transcutaneous pacing for immediate stabilization if medical therapy fails 1
  • Diagnostic evaluation:

    • 12-lead ECG to confirm diagnosis and identify associated conduction abnormalities
    • Transthoracic echocardiogram to exclude structural heart disease 1
    • Laboratory tests to rule out reversible causes (thyroid function, electrolytes, pH) 1

Definitive Management

Indications for Permanent Pacing

  • Class I recommendation (strong): Permanent pacemaker implantation for:

    • All patients with Mobitz type II AV block regardless of symptoms 1
    • Patients with high-grade AV block or third-degree AV block 1
  • Important considerations:

    • Mobitz type II block is abnormal and not a normal physiologic finding (unlike some cases of Mobitz type I/Wenckebach) 1
    • The site of block in Mobitz II is almost always below the AV node (infranodal) 2
    • High risk of progression to complete heart block with potential for Adams-Stokes syndrome and sudden death 3

Special Circumstances

  • Patients with neuromuscular diseases or infiltrative cardiomyopathies:

    • Permanent pacing with additional defibrillator capability if needed and meaningful survival >1 year is expected 1
  • Distinguishing from other conditions:

    • Important to differentiate true Mobitz II from 2:1 Wenckebach physiology
    • Exercise testing may help distinguish between the two 1
    • Electrophysiology study may be required in rare cases to determine the level of block 1

Follow-up Care

  • After pacemaker implantation:
    • Device check before discharge
    • Follow-up within 2-12 weeks of implantation
    • Regular device checks as per standard protocol (typically every 6-12 months)

Pitfalls and Caveats

  • Misdiagnosis risk: "Apparent Mobitz type II block" can occur in vagally-mediated AV block, which has a more benign prognosis 4, 5

  • Avoid delaying therapy: Do not delay permanent pacemaker implantation in confirmed Mobitz II block, even in asymptomatic patients, due to high risk of progression to complete heart block 3

  • Ineffective treatments: Atropine is often ineffective in Mobitz II block as the block is typically located in non-nodal tissue (bundle of His or more distal conduction system) 1

  • Pseudo AV block: Concealed His bundle or ventricular extrasystoles may mimic Mobitz II block and should be ruled out 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Second-degree atrioventricular block: Mobitz type II.

The Journal of emergency medicine, 1993

Research

Second-degree atrioventricular block revisited.

Herzschrittmachertherapie & Elektrophysiologie, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.